Liling Wan
Impact in
- Cancer Research top 5%
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Chromatin Remodeling and Cancer
- Mechanisms of cancer metastasis
Papers in
-
- Acute Myeloid Leukemia Research 5
- Oncology 6
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Yibin Kang (8 shared papers)Klaus Pantel (1 shared paper)Haitao Li (5 shared papers)C. David Allis (4 shared papers)Xiaobing Shi (3 shared papers)Hong Y. Wen (2 shared papers)Yuanyuan Li (2 shared papers)Robert G. Roeder (1 shared paper)
- Journals
- Cancer Discovery (3 papers)Nature Communications (2 papers)Nature (2 papers)Nature Cancer (2 papers)Molecular Cell (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Liling Wan
23 papers receiving 2k citations
Liling Wan's Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 272
- Molecular Biology 1.1k
- Oncology 358
- Hematology 174
- Pathology and Forensic Medicine 95
Countries citing papers authored by Liling Wan
This map shows the geographic impact of Liling Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Wan more than expected).
Fields of papers citing papers by Liling Wan
This network shows the impact of papers produced by Liling Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Wan. The network helps show where Liling Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Liling Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor metastasis: moving new biological insights into the clinic Hit paper breakdown → | 2013 | 657 |
| 2 | 2016 | 319 | |
| 3 | 2017 | 223 | |
| 4 | 2014 | 121 | |
| 5 | 2019 | 116 | |
| 6 | 2018 | 88 | |
| 7 | 2022 | 71 | |
| 8 | 2022 | 64 | |
| 9 | 2021 | 57 | |
| 10 | 2021 | 50 | |
| 11 | 2014 | 45 | |
| 12 | 2020 | 44 | |
| 13 | 2013 | 41 | |
| 14 | 2022 | 40 | |
| 15 | 2014 | 38 | |
| 16 | 2013 | 33 | |
| 17 | 2023 | 19 | |
| 18 | 2024 | 16 | |
| 19 | 2023 | 8 | |
| 20 | 2024 | 8 |
About Liling Wan
Liling Wan is a scholar working on Hematology, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (7 papers), Acute Myeloid Leukemia Research (5 papers), Cancer Cells and Metastasis (3 papers), Chromatin Remodeling and Cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related Molecular Pathways (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (272 citations), Molecular Biology (1.1k citations), Oncology (358 citations), Hematology (174 citations) and Pathology and Forensic Medicine (95 citations). Liling Wan has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Yibin Kang, Klaus Pantel, Haitao Li, C. David Allis, Xiaobing Shi, Hong Y. Wen, Yuanyuan Li, Robert G. Roeder, Yong Wei and Zhanyun Tang. Their work appears in journals such as Cancer Discovery, Nature Communications, Nature, Nature Cancer and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.